(EXLS) ExlService Holdings - Overview
Sector: Technology | Industry: Information Technology Services | Exchange: NASDAQ (USA) | Market Cap: 4.848m USD | Total Return: -35.6% in 12m
Industry Rotation: -18.7
Avg Turnover: 56.4M USD
Peers RS (IBD): 27.1
EPS Trend: -23.1%
Qual. Beats: 0
Rev. Trend: 99.4%
Qual. Beats: 4
Warnings
No concerns identified
Tailwinds
No distinct edge detected
ExlService Holdings, Inc. (EXLS) is a data and AI company operating globally. It offers digital operations, analytics, and AI-driven solutions across several sectors.
The companys primary segments include Insurance, Healthcare and Life Sciences, Banking, Capital Markets, and Diversified Industries. This diversified approach is common in the business process outsourcing (BPO) sector, which relies on economies of scale and specialized expertise.
EXLS provides a range of services such as claims management, premium administration, actuarial analytics, and underwriting support within the insurance industry. In healthcare, it focuses on care management, payment integrity, and revenue optimization. The company also offers financial planning, accounting, and regulatory reporting services, catering to the increasing demand for compliance and data-driven decision-making in financial services.
Its business model leverages software-as-a-service (SaaS) platforms like LifePRO and Subrosource, a common strategy for recurring revenue in technology-enabled service providers. Further research on ValueRay can provide deeper insights into EXLSs financial performance and market position.
- AI and data analytics demand fuels revenue growth
- Insurance sector spending drives service adoption
- Healthcare industry contracts boost service revenue
- Global economic slowdown impacts client spending
- Regulatory changes in financial services create compliance demand
| Net Income: 251.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.18 > 0.02 and ΔFCF/TA 3.78 > 1.0 |
| NWC/Revenue: 24.23% < 20% (prev 27.24%; Δ -3.01% < -1%) |
| CFO/TA 0.21 > 3% & CFO 350.7m > Net Income 251.0m |
| Net Debt (259.5m) to EBITDA (433.3m): 0.60 < 3 |
| Current Ratio: 2.56 > 1.5 & < 3 |
| Outstanding Shares: last quarter (162.5m) vs 12m ago -1.12% < -2% |
| Gross Margin: 38.37% > 18% (prev 0.38%; Δ 3.80k% > 0.5%) |
| Asset Turnover: 125.7% > 50% (prev 113.6%; Δ 12.15% > 0%) |
| Interest Coverage Ratio: 11.47 > 6 (EBITDA TTM 433.3m / Interest Expense TTM 30.1m) |
| A: 0.30 (Total Current Assets 830.0m - Total Current Liabilities 324.1m) / Total Assets 1.70b |
| B: 0.90 (Retained Earnings 1.53b / Total Assets 1.70b) |
| C: 0.21 (EBIT TTM 345.2m / Avg Total Assets 1.66b) |
| D: 1.71 (Book Value of Equity 1.35b / Total Liabilities 789.5m) |
| Altman-Z'' Score: 8.08 = AAA |
| DSRI: 0.84 (Receivables 343.1m/359.8m, Revenue 2.09b/1.84b) |
| GMI: 0.98 (GM 38.37% / 37.59%) |
| AQI: 0.96 (AQ_t 0.39 / AQ_t-1 0.41) |
| SGI: 1.14 (Revenue 2.09b / 1.84b) |
| TATA: -0.06 (NI 251.0m - CFO 350.7m) / TA 1.70b) |
| Beneish M-Score: -3.16 (Cap -4..+1) = AA |
Over the past week, the price has changed by -5.18%, over one month by -1.48%, over three months by -30.69% and over the past year by -35.63%.
- StrongBuy: 5
- Buy: 3
- Hold: 2
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 41.7 | 42.5% |
P/E Forward = 14.1844
P/S = 2.3223
P/B = 5.3013
P/EG = 1.0138
Revenue TTM = 2.09b USD
EBIT TTM = 345.2m USD
EBITDA TTM = 433.3m USD
Long Term Debt = 293.7m USD (from longTermDebt, last quarter)
Short Term Debt = 22.4m USD (from shortTermDebt, last quarter)
Debt = 405.8m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 259.5m USD (from netDebt column, last quarter)
Enterprise Value = 4.93b USD (4.85b + Debt 405.8m - CCE 328.4m)
Interest Coverage Ratio = 11.47 (Ebit TTM 345.2m / Interest Expense TTM 30.1m)
EV/FCF = 16.52x (Enterprise Value 4.93b / FCF TTM 298.1m)
FCF Yield = 6.05% (FCF TTM 298.1m / Enterprise Value 4.93b)
FCF Margin = 14.28% (FCF TTM 298.1m / Revenue TTM 2.09b)
Net Margin = 12.02% (Net Income TTM 251.0m / Revenue TTM 2.09b)
Gross Margin = 38.37% ((Revenue TTM 2.09b - Cost of Revenue TTM 1.29b) / Revenue TTM)
Gross Margin QoQ = 38.63% (prev 38.51%)
Tobins Q-Ratio = 2.89 (Enterprise Value 4.93b / Total Assets 1.70b)
Interest Expense / Debt = 4.12% (Interest Expense 16.7m / Debt 405.8m)
Taxrate = 20.18% (15.2m / 75.5m)
NOPAT = 275.5m (EBIT 345.2m * (1 - 20.18%))
Current Ratio = 2.56 (Total Current Assets 830.0m / Total Current Liabilities 324.1m)
Debt / Equity = 0.44 (Debt 405.8m / totalStockholderEquity, last quarter 912.7m)
Debt / EBITDA = 0.60 (Net Debt 259.5m / EBITDA 433.3m)
Debt / FCF = 0.87 (Net Debt 259.5m / FCF TTM 298.1m)
Total Stockholder Equity = 984.5m (last 4 quarters mean from totalStockholderEquity)
RoA = 15.12% (Net Income 251.0m / Total Assets 1.70b)
RoE = 25.50% (Net Income TTM 251.0m / Total Stockholder Equity 984.5m)
RoCE = 27.00% (EBIT 345.2m / Capital Employed (Equity 984.5m + L.T.Debt 293.7m))
RoIC = 21.36% (NOPAT 275.5m / Invested Capital 1.29b)
WACC = 7.82% (E(4.85b)/V(5.25b) * Re(8.20%) + D(405.8m)/V(5.25b) * Rd(4.12%) * (1-Tc(0.20)))
Discount Rate = 8.20% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.33%
[DCF] Terminal Value 82.18% ; FCFF base≈267.8m ; Y1≈330.3m ; Y5≈563.6m
[DCF] Fair Price = 62.64 (EV 10.06b - Net Debt 259.5m = Equity 9.80b / Shares 156.4m; r=7.82% [WACC]; 5y FCF grow 25.0% → 3.0% )
EPS Correlation: -23.06 | EPS CAGR: -43.82% | SUE: -4.0 | # QB: 0
Revenue Correlation: 99.41 | Revenue CAGR: 14.25% | SUE: 3.52 | # QB: 4
EPS next Quarter (2026-06-30): EPS=0.53 | Chg7d=+0.000 | Chg30d=+0.000 | Revisions Net=-2 | Analysts=8
EPS current Year (2026-12-31): EPS=2.18 | Chg7d=+0.000 | Chg30d=+0.000 | Revisions Net=-2 | Growth EPS=+11.8% | Growth Revenue=+10.4%
EPS next Year (2027-12-31): EPS=2.45 | Chg7d=-0.002 | Chg30d=-0.002 | Revisions Net=-2 | Growth EPS=+12.2% | Growth Revenue=+10.5%
[Analyst] Revisions Ratio: -0.50 (1 Up / 3 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 3.2% (Discount Rate 8.2% - Earnings Yield 5.0%)
[Growth] Growth Spread = +7.3% (Analyst 10.5% - Implied 3.2%)